Montelukast Prescribing at RIVERSIDE SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,815
Total Quantity
38.5K
NHS Cost
£1.9K
vs National Avg
+165.1%
RIVERSIDE SURGERY prescribed 1,815 items of Montelukast over the last 12 months at a cost of £1,912 to the NHS. This is 165.1% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
142
Jun 2026
135
Jun 2026
162
Jun 2026
149
Jun 2026
152
Jun 2026
158
Jun 2026
162
Jun 2026
156
Jun 2026
155
Jun 2026
144
Jun 2026
134
Jun 2026
166
Prescribing Details
| Total Items | 1,815 |
|---|---|
| Total Quantity | 38,472 |
| Total NHS Cost | £1,912 |
| Presentations | 4 different forms |
| vs National Average | +165.1% |
Montelukast Prescribing Comparison
| This practice | 1,815 items |
|---|---|
| National average per practice | 685 items |
| Difference | +165.1% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.